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Salivary cortisol levels as a predictor of preeclampsia in adolescents
Niveles de cortisol salivario como predictor de
preeclampsia en adolescentes
Jaime Salvador-Moysén, MD1, José M. Ramírez-Aranda, MD2,
Yolanda Martínez-López, ScD1, Marisela Aguilar-Durán, MSc1
Summary
Objective: To determine the usefulness of salivary cortisol as a predictor of preeclampsia in adolescents.
Methods: We carried out a nested case-control study. Somatometric, clinical, and biochemical data were obtained
from 100 healthy pregnant adolescents and salivary cortisol was measured at 8:00, 12:00, and 20:00 hours on two
occasions during pregnancy, before 20 weeks, and after 30 weeks of gestation. The cortisol values between the group
of healthy pregnant women and the group that developed preeclampsia were compared by using the Student’s t, Mann-
Whitney, and Wilcoxon tests. Also, the ROC curve of cortisol values and the Positive and Negative Predictive values
of cortisol were estimated.
Results: Values >14.9 nmol/L of cortisol were observed in the group that developed preeclampsia, providing a
positive predictive value of 1 (100%). Values <10.1 nmol/L were observed in the control group, the negative
predictive value was 1 (100%). The cutoff point of the ROC curve -before 20 weeks of gestation- in the members of
the cohort was 13.9 nmol/L.
Conclusions: The salivary cortisol values observed in the two evaluations made to each of the groups showed
statistically significant differences between the groups at 8 and 12 hours of the day. The values obtained enable
establishing gradients that allow separating the group of healthy women that got ill with preeclampsia from the group
that did not develop the illness before week 20. After week 30, the cortisol gradients are established more clearly in
the group with preeclampsia and in the control group. The validation of these findings in larger samples would allow
implementing this procedure as a screening test for preeclampsia in groups of pregnant adolescents.
Keywords: Pregnancy in Adolescence; Pre-Eclampsia; Physiological Stress; Salivary cortisol.
 Colomb Med. 2012; 43: 46-53
Resumen
Objetivo: Determinar la utilidad del cortisol salivario como un predictor de preeclampsia en adolescentes.
Métodos: Se realizó un estudio de casos y controles anidado en una cohorte.Se obtuvieron datos somatométricos,
clínicos y bioquímicos, de un grupo de 100 mujeres adolescentes, embarazadas y sanas. Se les cuantificó cortisol
salivario a las 8:00, 12:00 y 20:00 h en dos ocasiones durante el desarrollo de su proceso gestacional, antes de la semana
20 y después de la semana 30. Los valores de cortisol obtenidos, tanto en el grupo de mujeres que permanecieron sanas,
como en el que desarrolló preeclampsia, se compararon empleando las pruebas t de Student, Mann-Whitnney y
Wilcoxon; también se estimaron los valores predictivos y la curva ROC para los valores de cortisol.
Resultados: El grupo que se convirtió en casos presentó valores de cortisol >14.9 nmol/L con un valor predictivo
de 1 (100%) en relación con la ocurrencia de preeclampsia; el grupo que fue seleccionado como control tuvo valores
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de cortisol <10.1 nmol/L con un valor predictivo de 1
(100%) en relación con la no ocurrencia de preeclampsia.
El punto de corte identificado -antes de la semana
gestacional 20- en la curva ROC para las integrantes de
toda la cohorte fue 13.9 nmol/L.
Conclusiones: Los valores de cortisol salivario, que
se obtuvieron en las dos evaluaciones realizadas a las
integrantes de cada uno de los grupos, mostró diferencias
estadísticamente significativas intergrupales a las 8:00 y
12:00 h del día. Los valores obtenidos permiten establecer
gradientes que separan antes de la semana 20, al grupo de
mujeres saludables que desarrollaron un cuadro de
preeclampsia del grupo de mujeres que no presentaron la
enfermedad. Después de la semana 30 los gradientes de
cortisol entre el grupo con preeclampsia y el grupo
control se definen más nítidamente. La validación de
estos hallazgos en muestras poblacionales mayores per-
mitirá la implementación de este procedimiento como
una prueba de tamizaje aplicable a grupos de adolescentes
embarazadas.
Palabras clave. Embarazo en adolescentes;
Pre-eclampsia; Estrés fisiológico; Cortisol salivario.
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Toxemias of pregnancy represent some of the
most relevant problems in reproductive health.
Preeclampsia is a hypertensive disorder that affects
3% to 10% of pregnancies and causes 15 to 20% of
deaths related to reproduction in developed countries;
it is also the number one cause of maternal death in
developing countries and an important cause of
perinatal death, preterm birth, and intrauterine growth
restriction1-3. The etiology of toxemia of pregnancy is
unknown, despite the large amount of research carried
out on the subject. One of the reasons that can
explain this is the lack of studies incorporating relevant
findings from different cognitive fields to explain the
origin of the disease. For example, the epidemiological
findings associated with the disease are not usually
considered in the research from a clinical point of
view. Also, the clinical and molecular evidence related
with the toxemias are not incorporated in the
epidemiological designs4-7.
Another explanation derives from the absence of
a guideline that links the socio-epidemiological varia-
bles of vulnerable population groups (low educational
levels, unstable family economy, low social support)
with the clinical and biochemical aspects of the
disease, which has limited the construction of a
general principle to explain the genesis of this health
problem. It is important to mention that it has been
documented that psychological stress and psycho-
social stress have both been associated with
preeclampsia in women from different social and
geographic settings8-12. From this perspective, the
concept of stress is operationally defined as: a
psychobiological process mediator, whose physio-
logical, biochemical, and molecular levels are the
translation of the individual’s organic response to
stimuli from various socio-cultural environments
they perceive as threatening9. According to this
evidence, we can hypothetically say that high levels of
psychological and psychosocial stress will necessarily
appear in the biochemical aspect. If this hypothesis is
valid, it will lead to new paths to solving this millennial
health problem.
The main purpose of this study was to evaluate
salivary cortisol as a positive, as well as a negative,
predictor of preeclampsia13 in pregnant adolescents.
Also, to biologically establish - through cortisol- the
findings reported in literature that establish the
association of psychological and psychosocial stress
with the occurrence of preeclampsia. The selection
of cortisol was based on information documented to
measure stress conditions in different population
groups14-16.
Materials and methods
Study participants. A cohort of 100 healthy
pregnant adolescents was formed to evaluate the
predictive capacity of cortisol as an early indicator of
preeclampsia. We designed a nested case-control
study to reach this goal. The participants were recruited
from two settings; institutional and community. The
inclusion criteria were: 1) age 15 to 20 years (The
upper age limit was 20 years old because the lack of
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personal economic and solvency and autonomy were
attributes shared within the group of adolescent
women and, for this study purpose, this condition
was more important than chronological age); 2)
gestation of <20 weeks; 3) adolescent with up to 3
pregnancies; 4) voluntarily and informed participation
in the study. The exclusion criterion was pregnant
adolescents with a history of metabolic and/or
vascular processes. The definition of preeclampsia
was: systolic blood pressure >140 mm Hg or diastolic
blood pressure > 90 mm Hg, and proteinuria >300
mg/urine of 24 hours.
The sample size was calculated by using a formula
applicable to cohort studies17:
                           2(Zα +Zβ)
2 p(1-p)
                                   (Po-Pe)2
Zα = 1.96
Zβ = 0.84
Po = 0.04
Pe = 0.175
p = 0.107
f = 0.15
n = 96
The recruitment and evaluation of study
participants was carried out from July 2002 to October
2004.
Procedure. The first evaluation was carried out
on gestational week 15 on average and the second on
week 32 on average. Somatometric, clinical, and
biochemical (cortisol) data were obtained. Calibrated
equipment and standardized technique were also
used. Socio-demographic data was recorded on the
first evaluation.
Recruitment was performed by identifying
pregnant adolescents in two Health Clinics of the
Ministry of Health of the State of Durango, Mexico.
We also included pregnant adolescents from the
community by using a census done by the Ministry of
Health and the Mexican Social Security Institute
from the same city. The evaluations were carried out
in an institutional setting, as well as in the community,
depending on the place where the pregnant
adolescents were recruited. The control group was
made up of 20 adolescents (four controls for each
case) randomly chosen from the group that did not
develop a pathologic process during pregnancy and
that had complete somatometric, clinical, and
biochemical evaluations in the two gestational stages
included in the study design.
Demographic, clinical, and somatometric
data. The demographic data collected by interview
and recorded in a questionnaire designed for this
purpose were: age, marital status, educational level,
and occupation. Blood pressure was measured by
using two new, portable, calibrated mercury column
sphygmomanometers. We followed the recommen-
dations established by the Official Mexican Norm,
NOM-030-SSA2-1999, with regard to the observer,
the subject, and the surroundings18. Height and weight
recordings were made with a new calibrated stadi-
meter, according to recommendations suggested by
the World Health Organization and the Pan American
Health Organization19. We calculated mean blood
pressure, body mass index (BMI) -before the 20th
week of gestation- and the expected weight for their
height and gestational age19 -after the 30th week of
gestation.
Salivary cortisol measurement. Three saliva
samples were collected to determine cortisol levels
by using a Salivette system (Sarstedt, AG & Co,
Nümbrecht, Germany) at three different moments
during the same day, 8:00, 12:00, and 20:00 h, before
gestational week 20 and on a second occasion after
week 30. The samples were centrifuged at 1000 g for
5 min, decanted to preserve the saliva without mucus,
and frozen at -20°C until analysis.
The concentration of salivary cortisol was
determined by immunoassay on microplates
(Active®Cortisol EIA, Diagnostic System Labora-
tories, Inc. Webster, TX). We added 100 µl of enzyme
conjugate to 25 µl of each control or standard sample
and then covered and mixed them for 10 seconds.
Afterwards, 100 µl of cortisol antiserum was added
and the samples were incubated at room temperature
for 45 min with continuous shaking at 700 rpm.
n=1/ (1-f)=
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Washings and aspiration were performed for five
cycles by using washing buffer with a semiautomatic
microplate washer. Thereafter, 100 µl of TBM
chromogen solution was added and the samples were
incubated at room temperature for 15 min with
continuous shaking at 700 rpm. We added 100 µl of
stop buffer and determined the cortisol concentration
with an ELx800 (Lionheart Diagnostics, Marshall
MI.) universal plate reader at 450 nm14.
Cortisol readings were performed in blind fashion
with regard to the clinical condition of the cohort
participants.
Statistical analyses. We analyzed the data with
the Student’s t, Mann-Whitney, and Wilcoxon tests.
A p<0.05 was considered statistically significant. We
used Microsoft Excel 2000 for data collection and
SPSS version 7.5 for statistical analysis. Also, the
ROC curve of cortisol values and the positive and
negative predictive values of cortisol were estimated.
Ethical considerations. All cohort participants
provided informed consent and the project was
approved by the Ethics Committee of the «Dr. José
Eleuterio González» University Hospital of Univer-
sidad Autónoma de Nuevo León.
Results
Definition of analysis groups was made when all
cohort participants ended their pregnancy. Five cases
of preeclampsia were diagnosed and confirmed in the
gynecology-obstetrics service of the Health Ministry’s
General Hospital in Durango, Mexico. The controls
were 20 adolescents (four for each case) randomly
chosen from the group with complete somatometric,
clinical, and biochemical evaluations that did not
develop preeclampsia.
Mean age of the case group was 17 years ±1 SD;
while in the control mean age was 17±1.9 SD. Only
one participant (20%) was married in the case group
and 15 (75%) were either married or had a partner in
the control group. The educational level observed
was 9 years in cases and 8.2 years in the control group.
Four (80%) cases and 14 (70%) controls were
housewives; one case (20%) and three (15%) controls
were students and only one (15%) control was a
worker. The percentage values observed in the con-
trol group are very similar to the values obtained in
the subjects in the cohort who did not develop
preeclampsia and that did not differ significantly
from the case group, with the exception of marital
status. Average values of mean blood pressure
(2DBP+1SBP/3) during both evaluations performed
on the case group were 65.5±3.3 SD and 84.7±16.2
SD with a 19 mm Hg increase being observed between
the first and second evaluation (for analysis purposes,
five adolescents who developed preeclampsia were
considered as the case group in the two moments of
evaluation before week 20 and after week 30. The
same applies to the 20 adolescents in the control
group). In the control group, the readings obtained
were 74.5 mm Hg±6.5 SD and 77.4±8.6 SD on the
first and second evaluation, respectively. The increase
observed between both measurements was 2.9 mm
Hg. This is 6.5 times less than that observed in the
cases.
With regard to the body mass index (BMI), the
data recorded during the initial measure (before week
20 of gestation) showed the following average results:
cases 22.1±3.4 SD; control group 21.9±2.9 SD; in the
second anthropometric measurement, the expected
weight for their height and gestational age was estimated19.
This represents a more appropriate evaluation after
week 20 of pregnancy, observing in the case group a
value of 103.8±8.5 SD and in the control group a
value of 97.7±10.4 SD -the normal range was establi-
shed between 90 and 12019- (Table 1).
The findings obtained by measuring salivary
cortisol (Table 2), (Figure 1) at 8.00 and 12.00 h, at
different moments during pregnancy showed
statistically significant differences when the case group
is compared with controls; the values observed at
20.00 h, were similar in both groups. The cutoff point
of the ROC curve -before 20 weeks of gestation- in
the members of the cohort was 13.9 nmol/L  with a
100% of sensitivity and 99% of specifity. The group
of participants who did not develop preeclampsia
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Table 1
Clinical and somatometric variables for cases and controlsa
 Cases   n= 5         Controls   n= 20          pb
Weeks of gestation
  Initial 15.0 (4.1) 14.5 (4. 2) 0.83
  Final 35.0 (4.9) 32.6 (2.9) 0.25
Mean arterial pressure
  Initial 65.5 (3.3) 74.5 (6.5) 0.004
  Final 84.7 (16.2) 77.4 (8.6) 0.24
  pc 0.04 0.21
Somatometric dates
  Before 20 weeksd 22.1 (3.4) 21.9 (2.9) 0.974
  After 30 weekse 103.8 (18.5) 97.7 (10.4) 0.53
a  mean (SD)         b  Mann-Whitney Test            c Wilcoxon test (initial vs. final values)         d  Body mass index
e Expected weight for height and gestational age (normal range was established between 90 and 120)19
Table 2
Cortisol values for cases and controls
Weeks of gestation       Cortisol nmol/L      p*
Cases   n= 5         Controls   n= 20
    mean σ        mean σ
Before 20
  8 am 14.9 (0.5) 10.1 (1.1) 0.00
12 noon 9.1 (2.1) 5.9 (1.5) 0.00
  8 pm 3.3 (1.7) 2.9 (1.2) 0.40
After 30
   8 am 18.2 (0.8) 11.7 (1.6) 0.00
12 noon 12.2 (1.3) 8.7 (1.8) 0.00
  8 pm 5.6 (2.4) 5.1 (1.9) 0.57
* Student´s t-test for independent samples
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and from which controls were selected is within the
range set between 5.9 nmol/L and 13.93 nmol/L.
The group of adolescents who developed pre-
eclampsia is exclusively within the range established
between 14.9 nmol/L and 16.78 nmol/L (Table3).
The positive and negative predictive value of sali-
vary cortisol was 1 (100%) (Table 4).
Discussion
The positive predictive value20 of salivary cortisol
with regard to preeclampsia was 1 (100%) with
cortisol levels >14.9 nmol/L; with levels <10.1 nmol/
L, the negative predictive value was 1(100%). These
results, using salivary cortisol as an indicator of
Table 3
ROC curve results of cortisol values in pregnant adolescents
Positive if Greater Than or Equal To (a)    Sensitivity 1 - Specificity
5.9000 1.000 1.000
7.0350 1.000 0.982
7.7250 1.000 0.964
8.3450 1.000 0.929
8.4800 1.000 0.911
8.6900 1.000 0.857
8.9650 1.000 0.839
9.2400 1.000 0.821
9.3950 1.000 0.768
9.4200 1.000 0.750
9.5450 1.000 0.732
9.7950 1.000 0.607
10.0700 1.000 0.554
10.3450 1.000 0.446
10.6200 1.000 0.286
11.0350 1.000 0.196
11.4500 1.000 0.161
11.7250 1.000 0.125
12.0000 1.000 0.054
12.6900 1.000 0.018
13.9300 1.000 0.000
14.7050 0.800 0.000
14.9850 0.600 0.000
15.4550 0.400 0.000
15.7550 0.200 0.000
16.7800 0.000 0.000
Percentile distribution of cortisol values obtained before gestational week 20, in the members of the cohort of pregnant
adolescents
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Table 4
Contingency table of salivary cortisol values and
preeclampsia (before 20 weeks of gestation)
Salivary cortisol            Preeclampsia
                                       Presenta              Absentb
Positive
  >14.9 nmol/L                    5                           0
Negative
 <10.1 nmol/L                      0                        20
a  PPV = TP/TP + FP = 5/5 = 1
b   NPV = TN/TN + FN = 20/20 = 1
0
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Figure 1. Salivary cortisol levels in pregnant
adolescents
biochemical stress, show epidemiological coherence20,
with different authors’ observations, in different
epidemiological approaches related to the association
of psychological and psychosocial stress conditions
with toxemias of pregnancy8-12. It is important to
mention that evidence is insufficient in scientific
publications that validate the cortisol and preeclampsia
findings presented herein, such as Sikkema et al.21
who evaluated cortisol levels in a group with
preeclampsia patients and compared to a control
group. The values observed in affected patients were
less than those for the control group, and statistically
significant differences were not observed. Something
remarkable in the Sikkema et al., work is that, in the
case group, the drop in cortisol values during the first
evaluation (week 17-18) is abrupt between 8 and 10
h, reducing by almost 40%, contrary to the control
group, whose reduction was almost 12%, meaning
3.3 times less. In the second evaluation made in the
same study (week 27-28), although observing the
same pattern with less magnitude, the curve in the
case group loses continuity showing irregularities not
observed in the control group; this unusual finding in
the circadian behavior of cortisol levels, observed in
the group with preeclampsia -clearly showed on
graphics by the authors- could have a relevant clinical
meaning, associated to stress conditions that, though
it was not possible to statistically demonstrate, does
not exclude the possibility of alteration of the
hypothalamic-pituitary-adrenal system of women with
preeclampsia. It is important to note that the average
age in the Sikkema et al.21 study was of 30 years; rather,
in the work we conducted, the average age of the
participants was 17 years, which implies possible
different neuroendocrine and metabolic conditions
attributable to age. On the other hand, there is
evidence of a clear increase in salivary cortisol levels,
with statistically significant values, in a group of
pregnant women to whom an experimental stressor
was applied16.
The rigorous methodology used during the study,
as well as to perform the first cortisol measure before
the 20th week of pregnancy support the validity of our
conclusions, although the reduced number of
preeclampsia cases could mean that the conclusions
obtained could be preliminary and not definitive
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although reasonably valid.
Validation of these findings in a larger sample and
in different geographical contexts would allow
implementing an early screening test -in institutional,
as well as community settings- in groups of pregnant
adolescents to confidently identify those at risk for
preeclampsia.
It is important to carry out studies that include, in
articulated and coherent manner, the most important
socio-epidemiological, clinical, and biochemical risk
factors and indicators documented in the literature
that are related to preeclampsia. This new way of
approaching the problem would provide a wider and
possibly more promising perspective to identify the
cause of the disease.
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